FILE PHOTO: Logos of Pfizer at the company’s booth at the 8th China International Import Expo (CIIE) in Shanghai, China, November 6, 2025.REUTERS/Maxim Shemetov/File Photo (Reuters) -Mikael Dolsten, ...
Novo Nordisk said that Mikael Dolsten has decided to pull out from his proposed appointment to the company's board of directors for personal reasons. The Danish drugmaker is holding a special ...
Dr. Dolsten, former Chief Scientific Officer and President of Worldwide Research, Development, and Medical at Pfizer, brings leadership experience spanning approximately 50 regulatory approvals and ...
Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) announced today that Mikael Dolsten, M.D., Ph.D., has joined the company’s board of directors as of March 1. Most recently, Dr. Dolsten served for more ...
(Reuters) -Mikael Dolsten, Pfizer's former research and development chief, has withdrawn his candidacy for Novo Nordisk's board, citing personal reasons, the Danish drugmaker said on Thursday. Dolsten ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results